![Debra Zack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Debra Zack
Directeur Technique/Scientifique/R&D chez
SPERO THERAPEUTICS, INC.
Fortune : 189 904 $ au 31/07/2026
Profil
Debra Jeske Zack is currently Chief Medical Officer at Spero Therapeutics, Inc. since 2026.
Former positions include Chief Medical Officer at Exagen, Inc. from 2020 to 2022, Executive Director-Global Product Area at Amgen, Inc., Vice President-Clinical Development at Xencor, Inc., and Associate Professor at the University of California, Los Angeles.
Education includes undergraduate studies at Texas Christian University and a doctorate from The University of Texas Southwestern Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/08/2026 | 162 311 ( 0,28% ) | 189 904 $ | 31/07/2026 |
Postes actifs de Debra Zack
| Sociétés | Poste | Début |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 27/07/2026 |
Anciens postes connus de Debra Zack
| Sociétés | Poste | Fin |
|---|---|---|
| EXAGEN INC. | Directeur Technique/Scientifique/R&D | 05/12/2022 |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
| XENCOR, INC. | Corporate Officer/Principal | - |
Formation de Debra Zack
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas Christian University
 Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exagen, Inc.
 Exagen, Inc. Medical/Nursing ServicesHealth Services Operates as a commercial-stage diagnostics company | Health Services |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
